reglab/housing_qa huggingface dataset:
HI Rev Stat § 329B-7 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329B. Substance Abuse Testing|329B-7 Remedies.

  §329B-7 Remedies. [(a)] Any person, agency, or entity that wilfully and knowingly violates any provision of this chapter shall be fined not less than $1,000 but not more than $10,000 for each violation as set by the department, plus reasonable court costs and attorney's fees as determined by the court, which penalty and costs shall be paid to the aggrieved person. This subsection shall not be construed as limiting the right of any person or persons to recover actual damages.  (b) In addition to any other enforcement mechanism allowed by law, any person, agency, or entity that commits, or proposes to commit, any act in violation of this chapter may be enjoined therefrom by a court of competent jurisdiction. An action for injunctive relief under this subsection may be brought by any aggrieved person that will fairly and adequately represent the interests of the protected class. [L 1990, c 236, pt of §1]
HI Rev Stat § 329B-8 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329B. Substance Abuse Testing|329B-8 Rulemaking.

  §329B-8 Rulemaking. The department may adopt rules under chapter 91 necessary to implement this chapter. [L 1990, c 236, pt of §1]
HI Rev Stat § 329C-1 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329C. Imitation Controlled Substances Act|329C-1 Definitions.

  §329C-1 Definitions. Whenever used in this chapter, unless the context otherwise requires:  "Controlled substance" means a substance as defined in section 329-1.  "Distribute" means the actual, constructive, or attempted transfer, delivery, or dispensing to another of an imitation controlled substance.  "Imitation controlled substance" means a substance that is not a controlled substance, which by dosage unit, appearance (including color, shape, size, and markings), or by representations made, would lead a reasonable person to believe that the substance is a controlled substance. In any case when the appearance of the dosage unit is not reasonably sufficient to establish that the substance is an "imitation controlled substance" (for example in the case of powder or liquid), the court or authority concerned shall consider, in addition to all other logically relevant factors, the following factors as related to representations made in determining whether the substance is an imitation controlled substance:  (1) Statements made by an owner or by anyone else in control of the substance concerning the nature of the substance, or its use or effect;  (2) Statements made to the recipient that the substances may be resold for inordinate profit;  (3) Whether the substance is packaged in a manner normally used for illicit controlled substances;  (4) Evasive tactics or actions utilized by the owner or person in control of the substance to avoid detection by law enforcement authorities;  (5) Prior convictions, if any, of an owner, or anyone in control of the object, under state or federal law related to controlled substances or fraud; and  (6) The proximity of the substances to controlled substances.  "Manufacture" means the production, preparation, or repackaging, labeling, or relabeling, of an imitation controlled substance. [L 1984, c 222, pt of §1]
HI Rev Stat § 329C-2 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329C. Imitation Controlled Substances Act|329C-2 Offenses.

  §329C-2 Offenses. (a) No person shall manufacture, distribute, or possess with intent to distribute, an imitation controlled substance. Any person who violates this subsection shall be guilty of a misdemeanor.  (b) No person eighteen years of age or over shall violate subsection (a) by distributing an imitation controlled substance to a person under eighteen years of age. Any person who violates this subsection shall be guilty of a class C felony.  (c) No person shall use, or possess with intent to use, an imitation controlled substance. Any person who violates this subsection shall be guilty of a petty misdemeanor, except that possession of a substance imitating a controlled substance which is subject to section 712-1249 shall constitute a violation.  (d) No person shall place in any newspaper, magazine, handbill, or other publication, or post or distribute in any public place, any advertisement or solicitation with reasonable knowledge that the purpose of the advertisement or solicitation is to promote the distribution of imitation controlled substances. Any person who violates this subsection shall be guilty of a misdemeanor.  (e) No civil or criminal liability shall be imposed by virtue of this chapter on any person registered under chapter 329 who manufactures, distributes, or possesses an imitation controlled substance for use as a placebo by a registered practitioner in the course of professional practice or research. [L 1984, c 222, pt of §1]
HI Rev Stat § 329C-3 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329C. Imitation Controlled Substances Act|329C-3 Forfeiture.

 §329C-3 Forfeiture. All imitation controlled substances are subject to forfeiture according to the procedures set forth in chapter 712A. [L 1984, c 222, pt of §1; am L 1989, c 261, §13]
HI Rev Stat § 329D-2.5 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329D. Medical Marijuana Dispensary System|329D-2.5 Office of medical cannabis control and regulation; established; duties.

 §329D-2.5 Office of medical cannabis control and regulation; established; duties. (a) There is established within the department the office of medical cannabis control and regulation, which shall report to the deputy director of health resources administration.  (b) The office of medical cannabis control and regulation shall administer medical cannabis dispensary licensure and regulation, pursuant to this chapter, and the registration of qualifying patients and primary caregivers, pursuant to part IX of chapter 329. [L 2018, c 159, §2]
HI Rev Stat § 329D-3 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329D. Medical Marijuana Dispensary System|329D-3 Qualifications for licensure.

  §329D-3 Qualifications for licensure. (a) Each application for a dispensary license shall include both an individual applicant and an applying entity.  (b) The application shall be submitted to the department and shall include supporting documentation to establish the following:  (1) That the individual applicant:  (A) Has been a legal resident of the State for not less than five years preceding the date of application;  (B) Is not less than twenty-one years of age; and  (C) Has had no felony convictions;  (2) That the applying entity:  (A) Has been organized under the laws of the State;  (B) Has a Hawaii tax identification number;  (C) Has a department of commerce and consumer affairs business registration division number and suffix;  (D) Has a federal employer identification number;  (E) Is not less than fifty-one per cent held by Hawaii legal residents or entities wholly controlled by Hawaii legal residents who have been Hawaii legal residents for not less than five years immediately preceding the date the application was submitted;  (F) Has financial resources under its control of not less than $1,000,000 for each license applied for, plus not less than $100,000 for each retail dispensing location allowed under the license applied for, in the form of bank statements or escrow accounts, and that the financial resources have been under the control of the applying entity for not less than ninety days immediately preceding the date the application was submitted; and  (G) Is composed of principals or members, each of whom has no felony convictions.  (c) A dispensary license shall not be sold or otherwise transferred from one person to another person. [L 2015, c 241, pt of §2]
HI Rev Stat § 329D-5 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329D. Medical Marijuana Dispensary System|329D-5 Medical cannabis dispensaries; selection.

 §329D-5 Medical cannabis dispensaries; selection.  (a) By January 4, 2016, the department shall provide for a selection process and criteria based on merit for verified applicants for medical cannabis dispensary licenses; provided that the selection process, at minimum, includes the criteria of section 329D-7(3).  (b) This selection process shall be utilized by the department to grant medical cannabis dispensary licenses. Licensees selected will be announced by April 15, 2016. A dispensary licensed pursuant to this chapter may begin dispensing not sooner than July 15, 2016, with the approval of the department. [L 2015, c 241, pt of §2; am L 2017, c 170, §2]
HI Rev Stat § 329D-5.5 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329D. Medical Marijuana Dispensary System|329D-5.5 Sale or transfer of dispensary license.

  §329D-5.5 Sale or transfer of dispensary license. (a) In the event of death, legal incapacity, or permanent disability of an individual dispensary licensee, the relevant entity licensee shall notify the department within thirty days of the individual licensee's inability to continue in the individual's capacity as a licensee, and shall provide to the department within thirty days of the notice a plan for the sale or transfer of the individual license to another individual who meets all the requirements under this chapter and has been a resident of the State for not less than five years preceding the proposed date of transfer.  (b) In the event of a voluntary resignation by an individual licensee, termination of an individual licensee's employment with an entity licensee with or without cause, or any other permanent separation of the relationship between an individual licensee and an entity licensee, the relevant entity licensee shall submit a plan to the department for approval at least thirty days prior to any sale or transfer of the individual license to another individual who shall meet all the requirements under this chapter and shall have been a resident of the State for not less than five years preceding the date of transfer.  (c) The department may deny a request for transfer of ownership if it deems the transferee has failed to meet all the requirements of section 329D-3 for ownership. [L 2019, c 240, §2]
HI Rev Stat § 329D-8 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329D. Medical Marijuana Dispensary System|329D-8 Laboratory standards and testing; laboratory certification.

 §329D-8 Laboratory standards and testing; laboratory certification. (a) The department shall establish and enforce standards for laboratory-based testing of cannabis and manufactured cannabis products for content, contamination, and consistency; provided that in establishing these standards, the department shall:  (1) Review and take guidance from the testing programs and standards utilized in other jurisdictions;  (2) Consider the impact of the standards on the retail cost of the product to the qualifying patient;  (3) Review and take guidance from the testing programs and standards for pesticides under the regulations of the United States Environmental Protection Agency;  (4) Consider processes that may allow cannabis or manufactured cannabis products that fail testing standards to be remediated;  (5) For the testing for microbiological impurities, consider the benefits of organically grown cannabis that features the use of bacteria in lieu of pesticides; and  (6) Include permission for qualifying patients and primary caregivers to obtain testing services directly from certified laboratories on the island where the qualifying patient and primary caregiver reside.  (b) The department may certify laboratories that can test cannabis and manufactured cannabis products prior to the sale of cannabis and manufactured cannabis products.  (c) If a dispensary licensee obtains a laboratory result indicating that a sample of a batch of its cannabis or manufactured cannabis products does not meet the department's standards for patient safety, the dispensary licensee, at its own expense, may have the same sample or a different sample from the same batch retested by the same laboratory or a different laboratory. If a retest at a different laboratory yields a different result, the department shall determine which result controls whether the batch may be approved for sale or whether further testing shall be required. [L 2015, c 241, pt of §2; am L 2017, c 41, §8 and c 170, §2; am L 2018, c 116, §16; am L 2020, c 38, §3] Revision Note  "Marijuana" changed to "cannabis" to conform to L 2017, c 170, pursuant to §23G-15.
HI Rev Stat § 329D-9 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329D. Medical Marijuana Dispensary System|329D-9 Manufacturing of medical cannabis products.

 §329D-9 Manufacturing of medical cannabis products. (a) Any medical cannabis dispensary licensed by the department pursuant to this chapter shall be permitted to manufacture cannabis products; provided that the dispensary shall also obtain any other state or county permits or licenses that may be necessary for a particular manufacturing activity.  (b) The department shall establish health, safety, and sanitation standards regarding the manufacture of manufactured cannabis products.  (c) A manufacturer of a manufactured cannabis product shall calculate the equivalent physical weight of the cannabis that is used to manufacture the product and shall make the equivalency calculations available to the department and to a consumer of the manufactured cannabis product. [L 2015, c 241, pt of §2; am L 2017, c 170, §2] Revision Note  "Marijuana" changed to "cannabis" to conform to L 2017, c 170, pursuant to §23G-15.
HI Rev Stat § 329D-10 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329D. Medical Marijuana Dispensary System|329D-10 Types of manufactured cannabis products.

  §329D-10 Types of manufactured cannabis products. (a) The types of medical cannabis products that may be manufactured and distributed pursuant to this chapter shall be limited to:  (1) Capsules;  (2) Lozenges;  (3) Pills;  (4) Oils and oil extracts;  (5) Tinctures;  (6) Ointments and skin lotions;  (7) Transdermal patches;  (8) Pre-filled and sealed containers used to aerosolize and deliver cannabis orally, such as with an inhaler or nebulizer; provided that containers need not be manufactured by the licensed dispensary but shall be filled with cannabis, cannabis oils, or cannabis extracts manufactured by the licensed dispensary; shall not contain nicotine, tobacco-related products, or any other non-cannabis derived products; and shall be designed to be used with devices used to provide safe pulmonary administration of manufactured cannabis products;  (9) Devices that provide safe pulmonary administration; provided that:  (A) The heating element of the device, if any, is made of inert materials such as glass, ceramic, or stainless steel, and not of plastic or rubber;  (B) The device is distributed solely for use with single-use, pre-filled, tamper-resistant, sealed containers that do not contain nicotine or other tobacco products;  (C) The device is used to aerosolize and deliver cannabis by inhalation, such as an inhaler, medical-grade nebulizer, or other similar medical grade volitization device;  (D) There is a temperature control on the device that is regulated to prevent the combustion of cannabis oil; and  (E) The device need not be manufactured by the licensed dispensary;  (10) Other products, including edible cannabis products, as specified by the department; and  (11) Other products as specified by the department.  (b) As used in this section, "lozenge" means a small tablet manufactured in a manner to allow for the dissolving of its medicinal or therapeutic component slowly in the mouth.  (c) As used in this section, "edible cannabis products" means manufactured cannabis products intended for gastrointestinal administration of any cannabinoid extracted from the cannabis plant and regulated as manufactured cannabis products and not as a "drug" or "food" as defined and regulated in chapter 328, or as "bottled water" as defined and regulated in chapter 328D.  (d) Any medical cannabis product manufactured pursuant to this chapter shall be regulated and approved by the department and meet all requirements of rules adopted pursuant to this chapter; provided that the department shall establish requirements for child-resistant packaging and accurate and proper labeling. [L 2015, c 241, pt of §2; am L 2016, c 230, §17; am L 2017, c 170, §2; am L 2018, c 116, §27; am L 2020, c 38, §4] Revision Note  In subsection (a)(8), "marijuana" changed to "cannabis" to conform to L 2017, c 170, pursuant to §23G-15.
HI Rev Stat § 329D-11 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329D. Medical Marijuana Dispensary System|329D-11 Advertising and packaging.

  §329D-11 Advertising and packaging. (a) The department shall establish standards regarding the advertising and packaging of cannabis and manufactured cannabis products; provided that the standards, at a minimum, shall require the use of packaging that:  (1) Is child-resistant and opaque so that the product cannot be seen from outside the packaging;  (2) Uses only black lettering on a white background with no pictures or graphics;  (3) Is clearly labeled with the phrase "For medical use only";  (4) Is clearly labeled with the phrase "Not for resale or transfer to another person";  (5) Includes instructions for use and "use by date";  (6) Contains information about the contents and potency of the product;  (7) Includes the name of the production center where cannabis in the product was produced, including the batch number and date of packaging;  (8) Includes a barcode generated by tracking software; and  (9) In the case of a manufactured cannabis product, includes a:  (A) Listing of the equivalent physical weight of the cannabis used to manufacture the amount of the product that is within the packaging, pursuant to section 329D-9(c);  (B) Clearly labeled warning stating that the product:  (i) Is a medication that contains cannabis, and is not a food; and  (ii) Should be kept away from children; and  (C) Date of manufacture.  (b) Any capsule, lozenge, or pill containing cannabis or its principal psychoactive constituent tetrahydrocannabinol shall be packaged so that one dose, serving, or single wrapped item contains no more than ten milligrams of tetrahydrocannabinol; provided that no manufactured cannabis product that is sold in a pack of multiple doses, servings, or single wrapped items, nor any containers of oils, shall contain more than a total of one thousand milligrams of tetrahydrocannabinol per pack or container; provided further that no dispensary shall exceed the dispensing limits imposed by section 329D-7.  (c) All manufactured cannabis products shall be individually wrapped at the original point of manufacture.  (d) The department shall be authorized to allow dispensaries to provide, disseminate, and publish educational and scientific materials relating to medical cannabis and its approved products and sponsor events about medical cannabis. [L 2015, c 241, pt of §2; am L 2017, c 170, §2; am L 2018, c 116, §28; am L 2020, c 38, §5] Revision Note  "Marijuana" changed to "cannabis" to conform to L 2017, c 170, pursuant to §23G-15.
HI Rev Stat § 329D-12 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329D. Medical Marijuana Dispensary System|329D-12 Background checks.

  §329D-12 Background checks. (a) The following shall be subject to background checks conducted by the department or its designee, including but not limited to criminal history record checks in accordance with section 846-2.7:  (1) Each applicant and licensee for a medical cannabis dispensary license, including the individual applicant and all officers, directors, members of a limited liability corporation; shareholders with at least twenty-five per cent or more ownership interest in a corporation; and managers of an entity applicant;  (2) Each employee of a medical cannabis dispensary;  (3) Each employee of a subcontracted production center or retail dispensing location;  (4) All officers, directors, members of a limited liability corporation; and shareholders with at least twenty-five per cent or more ownership interest in a corporate owner of a subcontracted production center or retail dispensing location; and  (5) Any person permitted to enter and remain in a dispensary facility pursuant to section 329D-15(a)(4) or 329D-16(a)(3). The person undergoing the background check shall provide written consent and all applicable processing fees to the department or its designee to conduct the background checks.  (b) This section shall not apply to:  (1) A qualifying patient, primary caregiver, qualifying out-of-state patient, or caregiver of a qualifying out-of-state patient who enters or remains on the premises of a retail dispensing location for the purpose of a transaction conducted pursuant to sections 329D-6 and 329D-13; or  (2) Government officials and employees acting in an official capacity and employees of a certified laboratory who enter or remain on the premises of a retail dispensing location or production center for any purpose authorized by this chapter. [L 2015, c 241, pt of §2; am L 2016, c 230, § §18, 19; am L 2017, c 170, §2; am L 2018, c 116, §17] Note  L 2016, c 230, §25(2) provides:  "SECTION 25. This Act shall take effect on July 1, 2016; provided that:  *** (2) Section 19 [amending §329D-12(a)] shall take effect on January 1, 2017, and shall not apply to medical marijuana dispensary license applications submitted on or before January 29, 2016; provided that section 19 shall apply to medical marijuana dispensary license renewal applications and to medical marijuana license applications submitted after January 29, 2016."
HI Rev Stat § 329D-13 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329D. Medical Marijuana Dispensary System|329D-13 Dispensing limits.

 §329D-13 Dispensing limits. (a) A qualifying patient, primary caregiver, qualifying out-of-state patient, or caregiver of a qualifying out-of-state patient shall be allowed to purchase no more than four ounces of cannabis within a consecutive period of fifteen days, or no more than eight ounces of cannabis within a consecutive period of thirty days.  (b) A qualifying patient, primary caregiver, qualifying out-of-state patient, or caregiver of a qualifying out-of-state patient may purchase cannabis from any dispensary location in the State, subject to the limits set forth in subsection (a).  (c) Beginning on January 1, 2018, this section may apply to qualifying out-of-state patients from other states, territories of the United States, or the District of Columbia; provided that the patient meets the registration requirements of section 329-123.5. [L 2015, c 241, pt of §2; am L 2018, c 116, §18] Revision Note  "Marijuana" changed to "cannabis" to conform to L 2017, c 170, pursuant to §23G-15.
HI Rev Stat § 329D-14 (2021)
2021 Hawaii Revised Statutes|Title 19. Health|329D. Medical Marijuana Dispensary System|329D-14 Prohibited acts related to exceeding limits; fraud; penalties.

 §329D-14 Prohibited acts related to exceeding limits; fraud; penalties. (a) It shall be unlawful for any person to obtain or attempt to procure any medical cannabis or medical cannabis product by:  (1) Fraud, deceit, misrepresentation, embezzlement, or theft;  (2) The forgery or alteration of a medical cannabis permit;  (3) Furnishing fraudulent medical information or the concealment of a material fact;  (4) The use of a false name or patient identification number, or the giving of a false address; or  (5) The alteration of a state issued medical use of cannabis permit card.  (b) Any person who violates subsection (a) shall be guilty of a class C felony. [L 2015, c 241, pt of §2; am L 2017, c 170, §2]